Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Honliv Healthcare Management Group Co Ltd (9906) AI Stock Analysis

Top Page

HK:9906

Honliv Healthcare Management Group Co Ltd

(HKEX:9906)

Select Model
Rating:51Neutral
Price Target:HKD 1.50â–¼(-3.85% Downside)
Action:initiatedcoverage
Date:07/19/25

Honliv Healthcare's overall score of 51 is primarily driven by mixed financial performance, with a stable balance sheet and improved cash flows offset by declining profitability margins. Technical indicators suggest caution due to overbought conditions and a longer-term downtrend, while valuation remains neutral with a reasonable P/E ratio but no dividend yield.

Positive Factors
Financial StabilityA strong equity position and low debt-to-equity ratio indicate financial stability, providing a solid foundation for future growth and resilience against economic fluctuations.
Negative Factors
Profit Margin PressureDeclining gross profit margins indicate rising cost pressures, which could challenge the company's ability to maintain profitability unless addressed through cost control or pricing strategies.

Honliv Healthcare Management Group Co Ltd (9906) vs. iShares MSCI Hong Kong ETF (EWH)

-5%0%5%10%15%20%HK:9906-3.11%EWH+7.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
HKD 936.00M
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
23.3
Beta (1Y)
-0.20
Revenue Growth
―
EPS Growth
―
Country
Hong Kong
Employees
1,955
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

Honliv Healthcare Management Group Co Ltd Business Overview & Revenue Model

Company Description

Honliv Healthcare Management Group Company Limited primarily owns and oversees the operations of a general hospital located in mainland China. The firm delivers a comprehensive suite of services, encompassing medical care, pharmaceutical provision, a...

How the Company Makes Money

Honliv Healthcare Management Group Co Ltd generates revenue through multiple streams. Primarily, the company earns money by providing management services to hospitals and healthcare facilities, which includes operational oversight, strategic planning...

Honliv Healthcare Management Group Co Ltd Financial Statement Overview

Summary

Honliv Healthcare shows mixed financial performance with stable but slow revenue growth (1.1% YoY), declining profitability margins (Net Profit Margin at 4.1%), a solid balance sheet (Debt-to-Equity Ratio of 0.31), and volatile yet improved cash flows (Free Cash Flow up 1452.9%). The score reflects strength in stability but concerns over profitability and consistency.

Income Statement

45Neutral

Balance Sheet

70Positive

Cash Flow

55Neutral
Financial statement breakdown
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue700.37M768.73M760.53M727.79M606.84M524.04M
Gross Profit100.87M126.69M144.84M138.40M135.31M137.59M
EBITDA99.35M125.80M119.31M127.13M98.20M79.43M
Net Income10.44M31.15M38.31M48.95M36.62M21.84M
Balance Sheet
Total Assets894.73M974.00M968.71M935.04M961.71M972.46M
Cash, Cash Equivalents and Short-Term Investments286.78M258.50M239.75M255.24M263.61M302.48M
Total Debt136.08M176.04M180.76M143.12M188.48M250.05M
Total Liabilities333.92M395.08M421.26M380.37M395.08M442.85M
Stockholders Equity554.90M573.00M541.85M549.47M561.83M525.21M
Cash Flow
Free Cash Flow78.49M31.19M2.01M98.66M40.08M-6.24M
Operating Cash Flow106.66M83.34M91.56M118.47M91.44M74.61M
Investing Cash Flow-19.39M-51.38M-88.76M-19.16M-50.46M-80.06M
Financing Cash Flow-60.68M-13.30M-19.12M-117.85M-76.87M215.16M

Honliv Healthcare Management Group Co Ltd Technical Analysis

Technical Analysis SentimentNegative
Last Price1.56

Price Trends

50DMA1.56Negative
100DMA1.56Negative
200DMA1.57Negative

Market Momentum

MACD-0.00Negative
RSI1.19Positive
STOCH100.00Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:9906, the sentiment is Negative. The current price of 1.56 is above the 20-day moving average (MA) of 1.56, below the 50-day MA of 1.56, and below the 200-day MA of 1.57, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 1.19 is Positive, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:9906.

Honliv Healthcare Management Group Co Ltd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

HK:9906 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HK:2219HK:221973OutperformHKD 1.66B8.346.97%10.27%3.85%-1.23%
HK:3309HK:330966NeutralHKD 1.05B10.105.57%2.35%4.75%―
HK:1846HK:184663NeutralHKD 703.50M285.710.20%2.00%20.54%-96.74%
HK:6078HK:607862NeutralHKD 5.84B27.812.55%―1.59%-58.55%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
HK:9906HK:990651NeutralHKD 936.00M23.355.59%―――
HK:3886HK:388641NeutralHKD 1.10B78.090.48%1.10%-3.26%―

* Healthcare Sector Average

Performance Comparison

-40%-20%0%HK:9906HK:1846HK:2219HK:3309HK:3886HK:6078Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
HK:9906 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HK:9906Honliv Healthcare Management Group Co Ltd1.56-0.05-3.11%
HK:1846EuroEyes International Eye Clinic Limited2.20-1.09-33.17%
HK:2219Chaoju Eye Care Holdings Ltd.2.360.010.43%
HK:3309C-MER Eye Care Holdings Limited0.85-0.91-51.81%
HK:3886Town Health International Medical Group Ltd.0.16-0.11-40.07%
HK:6078Hygeia Healthcare Holdings Co., Ltd.9.51-3.88-29.01%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Jul 19, 2025